Search Results 401-410 of 16225 for pharmacogenetics
The median survival is about 5 months from time of diagnosis. A Mayo Clinic-led study, published in the journal Science Translational Medicine , reveals the ...
Monoclonal antibodies, such as rituximab, may block cancer growth in different ways by targeting certain cells. Romidepsin and lenalidomide may stop the growth ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Chronic diseases are on the rise. Many have no easy treatment, some none at all. "As a medical institution, we won't accept that the current state of ...
About this study. Integration of Diabetes Prevention Program (DPP) and Diabetes Self Management Program (DSMP) into WellConnect.
The Somatic Mutations in Development and Aging Lab of Alexej Abyzov, Ph.D., at Mayo Clinic studies the effects of DNA changes that happen during a person's ...
The purpose of this study is to identify common genetic variants contributing to the risk of glioma. Evaluate gene-gene and gene-environmental interactions with ...
Mayo Clinic researchers have developed a new way to predict whether existing drugs could be repurposed to treat heart failure, one of the world's most[...] ...
All of Us is a service mark of the Department of Health and Human Services.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.